top of page
The eye.gnos management team worked with and for several partners in the pharma and CRO, investor and corporate world at immunology research projects and clinical programs including in inflammatory / autoimmune indications like multiple sclerosis, inflammatory bowel disease (ulcerative colitis / crohns disease), rheumatoid arthritis, lupus and other skin diseases  plus front and back of the eye indications, including:

Alcon Inc.

Allergan Inc.

Arva Ventures

Astellas

Assana

Bayer Pharma AG

Brace

Cutech Srl.

DSM Biomedical

ESBAtech

Heidelberg Engineering GmbH

Isarna Therapeutics

Kendle Inc.

Lumithera

Novartis Pharma AG

Novo Nordisk A/S

 

 

Oculis

Ophthotech Corp.

Ora

PAREXEL Int. Corp.

PPD LLC.

Regeneron Pharmaceuticals Inc.

Roche

Schering AG

Syntheract

TX Cell

Weleda AG

ZymoGenetics Inc.

 

 

... and many more.

 

bottom of page